Granulysin (GNLY),
IntroductionThe granulysin (GNLY) gene is located on chromosome 2 and consists of 6 exons. A major protein product of 15 kDa is translated, some of which is subsequently secreted or processed by proteolytic cleavage at both N and C termini to a 9-kDa protein stored in the granular compartment. 1 Whereas the 15-kDa protein is produced rapidly, has a shorter half-life, and is constitutively released, the secretory 9-kDa form is produced slowly and is relatively stable. The crystal structure of the human protein, elucidated in 2003 by Anderson et al, is predictive of its antimicrobial effects and clinical relevance in disease and pathogenesis. GNLY is highly cationic and folded as a 5-helix bundle stabilized by 2 highly conserved intramolecular disulfide bonds. 2 It belongs to the family of Saposin-like lipid binding proteins called SAPLIP and colocalizes in the granular compartments of cytotoxic T lymphocytes (CTLs) and natural killer (NK) cells along with granzymes and perforin. 3 GNLY has the highest sequence identity to NK-lysin (43% identity), a porcine protein with antibacterial activity that is also a member of the SAPLIP family. 3 No homologous protein has been identified to date in mice.GNLY is produced by human NK cells and activated CTLs, and the 9-kDa form is rapidly released upon degranulation. The kinetics of expression of GNLY by these 2 cell types differs. NK cells release GNLY very early in immune responses, whereas CTLs release it after 3-5 days of activation. 1 Elevation of GNLY expression and levels in tissue and serum has been reported in infections, autoimmune diseases, transplant rejection, and graft versus host reaction in patients with hematopoietic stem cell transplantation. [4][5][6][7][8][9][10] In leprosy, CD4 ϩ cells expressing GNLY were elevated (8%-15%) in the skin lesions of patients with the tuberculoid form compared with those with the disseminated lepromatous form of the disease. 7 Recent studies have demonstrated that in response to Mycobacterium tuberculosis-infected macrophages, human CD8 ϩ T cells were induced to express CCL5 and GNLY. 11 Recently, it was reported that blister fluids of patients suffering from Stevens Johnson syndrome and toxic epidermal necrolysis contained high levels of secretory 15-kDa GNLY, and the high concentration of GNLY, but not granzyme B or perforin, is responsible for the disseminated keratinocyte apoptosis in Stevens Johnson syndrome and toxic epidermal necrolysis. 12 By contrast, patients with severe immunodeficiencies have very low GNLY serum levels. 13 GNLY levels are also reduced in different cell types and even in serum of carcinoma patients and appear to be inversely correlated with tumor progression. 14-17 Consequently both forms of GNLY can be induced in the course of inflammation and have also been shown to be up-regulated by stimulation of lymphoid cells by proinflammatory mediators and pathogenassociated molecular patterns. 18,19 GNLY exhibits lytic activity against a variety of microorganisms and tumors. 3,14,[20][...